E-LIB Suche - Ergebnisse für: Pal, Parasar

1

First‐in‐human safety, tolerability, and pharmacokinetic re..:

Gatlik, Ewa ; Mehes, Beata ; Voltz, Emilie...
Clinical and Translational Science. 17 (2024) 5 - p. , 2024

2

Pharmacokinetic Interaction Between Fingolimod and Carbamaz..:

David, Olivier J. ; Behrje, Rhett ; Pal, Parasar...
Clinical Pharmacology in Drug Development. 7 (2018) 6 - p. 575-586 , 2018

Link: https://doi.org/10.1002/..

3

Effect of the angiotensin receptor–neprilysin inhibitor sac..:

Ayalasomayajula, Surya ; Schuehly, Uwe ; Pal, Parasar...
British Journal of Clinical Pharmacology. 84 (2018) 5 - p. 926-936 , 2018

Link: https://doi.org/10.1111/..

4

Effect of Fluconazole Coadministration and CYP2C9 Genetic P..:

Gardin, Anne ; Ufer, Mike ; Legangneux, Eric...
Clinical Pharmacokinetics. 58 (2018) 3 - p. 349-361 , 2018

Link: https://doi.org/10.1007/..

5

Pharmacodynamic interaction between intravenous nitroglycer..:

Schuehly, Uwe ; Ayalasomayajula, Surya ; Buchbjerg, Jeppe...
European Journal of Clinical Pharmacology. 74 (2018) 9 - p. 1121-1130 , 2018

Link: https://doi.org/10.1007/..

6

Systemic and tissue-specific effects of aliskiren on the RA..:

Engeli, Stefan ; May, Marcus ; Nussberger, Juerg...
Journal of the American Society of Hypertension. 11 (2017) 8 - p. 488-497 , 2017

Link: https://doi.org/10.1016/..

7

Pharmacokinetics and safety of sacubitril/valsartan (LCZ696..:

Kulmatycki, Kenneth M. ; Langenickel, Thomas ; Ng, Wai Hong...
Int. Journal of Clinical Pharmacology and Therapeutics. , 2017

Link: https://doi.org/10.5414/..

8

Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696):..:

Ayalasomayajula, Surya ; Langenickel, Thomas ; Pal, Parasar..
Clinical Pharmacokinetics. 56 (2017) 12 - p. 1461-1478 , 2017

Link: https://doi.org/10.1007/..

9

Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsart..:

Ayalasomayajula, Surya ; Langenickel, Thomas ; Pal, Parasar..
Clinical Pharmacokinetics. 57 (2017) 1 - p. 105-123 , 2017

Link: https://doi.org/10.1007/..

10

Single therapeutic and supratherapeutic doses of sacubitril..:

Langenickel, Thomas H. ; Jordaan, Pierre ; Petruck, Jesika...
European Journal of Clinical Pharmacology. 72 (2016) 8 - p. 917-924 , 2016

Link: https://doi.org/10.1007/..

11

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/..:

Kobalava, Zhanna ; Kotovskaya, Yulia ; Averkov, Oleg...
Cardiovascular Therapeutics. 34 (2016) 4 - p. 191-198 , 2016

Link: https://doi.org/10.1111/..

12

Effect of food on the oral bioavailability of the angiotens..:

Ayalasomayajula, Surya ; Langenickel, Thomas ; Chandra, Priya...
Int. Journal of Clinical Pharmacology and Therapeutics. 54 (2016) 12 - p. 1012-1018 , 2016

Link: https://doi.org/10.5414/..

13

Pharmacokinetics, Safety and Tolerability of Sacubitril/Val..:

Han, Yi ; Ayalasomayajula, Surya ; Pan, Wei...
European Journal of Drug Metabolism and Pharmacokinetics. 42 (2016) 1 - p. 109-116 , 2016

Link: https://doi.org/10.1007/..

14

Pharmacokinetics After Single Ascending Dose, Food Effect, ..:

Akahori, Mizuki ; Ayalasomayajula, Surya ; Langenickel, Thomas...
European Journal of Drug Metabolism and Pharmacokinetics. 42 (2016) 3 - p. 407-416 , 2016

Link: https://doi.org/10.1007/..

15

Assessment of Drug–Drug Interaction Potential Between Atorv..:

Ayalasomayajula, Surya ; Pan, Wei ; Han, Yi...
European Journal of Drug Metabolism and Pharmacokinetics. 42 (2016) 2 - p. 309-318 , 2016

Link: https://doi.org/10.1007/..